Written by: NoriYah Yisrael, MSM, PMP
Presentation Overview 
On March 9, 2023, the Clinical Research Forum of the PMI Atlanta Chapter hosted the “BioPharma PMO: How to Scale Up for A Growing Organization in the Clinical Research Industry” Special Industry Forum event as presented by NoriYah Yisrael. Mrs. Yisrael spoke to the audience and shared her vast knowledge of clinical trials in the healthcare industry, looking through a lens filled with 35 years of experience. Ms. Yisrael took the audience on a journey from the definition of drugs and devices through the discovery and commercialization of a product that survives it to the marketplace.
As the main topic, Ms. Yisrael engaged the audience and described how agility is, and could be further incorporated, at the Project Management Office (PMO) level to stay in alignment with biopharmaceutical companies as their pipeline grows. Gap Analyses and Maturity Assessments are only part of the solution. Leading the audience through the FDA’s adaptability during the COVID-19 pandemic, and how vaccine manufacturers pivoted to answer the desperate call of Americans for a timely solution, the story was painted clear about agility in the biopharmaceutical environment. Mrs. Yisrael provided statistics and data to inform how the rising costs of medicines may be offset if the industry further adapted their way of working, at both the project and enterprise levels. By introducing more agility in the way we do clinical trials, there is the potential to increase product speed to market and decrease the overall cost of biopharmaceutical research and development.
Takeaways
- As biopharmaceutical companies grow their pipeline, PMOs can stay in alignment and upscale their delivery model in accordance with that growth.
- Gap Analyses and PMO Maturity Assessments can be done to determine where the company is, and where the company endeavors to go, from a value-driven perspective. Together with an Agile mindset and an aptitude for change, PMOs have a roadmap wherewith to evolve strategically.
- By introducing agility into their way of working, biopharmaceutical companies can potentially reduce research and development expenses, and increase the speed to market for their medicinal products.
Next Event
Join us at the next PMI Atlanta Chapter Clinical Research Forum on June 8, 2023
Register at www.pmiatlanta.org/events/event-calendar
Event Pictures
